The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Insect Cells as a Factory to Produce Adeno-Associated Virus Type 2 Vectors
Abstract
Recombinant adeno-associated viruses (rAAV) are produced transiently in mammalian cells usually by cotransfecting two or three plasmids containing AAV genes, adenovirus helper genes, and a vector genome. Expansion and transfection of adherent cells limit the scale of rAAV production. Efficient transfection is performed with cells on solid support media such as tissue culture plates. A large animal study or a human clinical trial may require 10(15) particles of vector, depending on dose. To generate this quantity of rAAV by transfection, more than 10(11) HEK293 cells may be needed, which would require about 5000 x 175 cm(2) flasks. The ability to scale up rAAV production by these methods severely restricts the commercialization and use of AAV vectors. A recombinant baculovirus derived from the Autographa californica nuclear polyhedrosis virus is widely employed for large-scale production of heterologous proteins in cultured insect cells and may provide an attractive alternative. Toward this goal, we have explored the production of rAAV in invertebrate cells. Sf9 cells may be coinfected in suspension cultures with three recombinant baculoviruses (a Rep-baculovirus, a VP-baculovirus, and an AAV ITR vector genome baculovirus) and, 3 days later, rAAV is recovered. The particles produced are indistinguishable from 293 cell-produced rAAV, as determined on the basis of physical properties and biologic activities. Particles produced by either method were composed of similar proteins and nucleic acid. The yield of genome-containing particles produced per Sf9 cell approached 5 x 10(4), thus, 1000 ml of cultured Sf9 cells produced the equivalent of between 500 to 1000 x 175 cm(2) flasks of 293 cells. This robust system provides a simple, cost-effective method for AAV vector production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406
Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381
Kaplitt, M. G., Leone, P., Samulski, R. J., Xiao, X., Pfaff, D. W., O'Malley, K. L., & During, M. J. (1994) · Nature Genetics · doi:10.1038/ng1094-148 · Cited by 1,031
Kay, M. A., Manno, C. S., Ragni, M. V., Larson, P. J., Couto, L. B., McClelland, A., Glader, B., Chew, A. J., J Tai, S., Herzog, R. W., et al. (2000) · Nature Genetics · doi:10.1038/73464 · Cited by 1,022
Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells
Muzyczka, N. (1992) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75608-5_5 · Cited by 754
Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors
Grimm, D., Kern, A., Rittner, K., & Kleinschmidt, J. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2745 · Cited by 696
Kessler, P. D., Podsakoff, G. M., Chen, X., McQuiston, S. A., Colosi, P. C., Matelis, L. A., Kurtzman, G. J., & Byrne, B. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14082 · Cited by 614
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles
Kirnbauer, R., Taub, J. W., Greenstone, H. L., Roden, R. B. S., Dürst, M., Gissmann, L., Lowy, D. R., & Schiller, J. T. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.6929-6936.1993 · Cited by 608
Snyder, R. O., Miao, C. H., Patijn, G. A., Spratt, S. K., Danos, O., Nagy, D., Gown, A. M., Winther, B., Meuse, L., Cohen, L. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0797-270 · Cited by 579
Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus
Flannery, J. G., Zolotukhin, S., Vaquero, M. I., LaVail, M. M., Muzyczka, N., & Hauswirth, W. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6916 · Cited by 407
DNA helicase‐mediated packaging of adeno‐associated virus type 2 genomes into preformed capsids
King, J. A., Dubielzig, R., Grimm, D., & Kleinschmidt, J. A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.12.3282 · Cited by 338
Efficient lentiviral transduction of liver requires cell cycling in vivo
Park, F., Ohashi, K., Chiu, W., Naldini, L., & Kay, M. A. (2000) · Nature Genetics · doi:10.1038/71673 · Cited by 323
Hermonat, P. L., Labow, M. A., Wright, R., Berns, K. I., & Muzyczka, N. (1984) · Journal of Virology · doi:10.1128/jvi.51.2.329-339.1984 · Cited by 299
Tratschin, J. D., Miller, I. L., & Carter, B. J. (1984) · Journal of Virology · doi:10.1128/jvi.51.3.611-619.1984 · Cited by 270
Cell Lines for the Production of Recombinant Adeno-Associated Virus
Clark, K. R., Voulgaropoulou, F., Fraley, D. M., & Johnson, P. R. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.10-1329 · Cited by 257
Kajigaya, S., Fujii, H., Field, A., Anderson, S., Rosenfeld, S., Anderson, L. J., Shimada, T., & Young, N. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4646 · Cited by 249
Koeberl, D. D., Alexander, I. E., Halbert, C. L., Russell, D. W., & Miller, A. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1426 · Cited by 246
Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome
Surosky, R. T., Urabe, M., Godwin, S. G., McQuiston, S. A., Kurtzman, G. J., Ozawa, K., & Natsoulis, G. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7951-7959.1997 · Cited by 243
Self-citationProspects for the Use of Adeno-Associated Virus as a Vector for Human Gene Therapy
Kotin, R. M. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.7-793 · Cited by 238
Self-citationSubcellular compartmentalization of adeno-associated virus type 2 assembly
Wistuba, A., Kern, A., Weger, S., Grimm, D., & Kleinschmidt, J. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1341-1352.1997 · Cited by 219
High-Titer Adeno-Associated Viral Vectors from a Rep/Cap Cell Line and Hybrid Shuttle Virus
Gao, G.-P., Qu, G., Faust, L. Z., Engdahl, R. K., Xiao, W., Hughes, J. V., Zoltick, P. W., & Wilson, J. M. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.16-2353 · Cited by 194
Chiorini, J. A., Wendtner, C., Urcelay, E., Safer, B., Hallek, M. J., & Kotin, R. M. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.12-1531 · Cited by 112
Self-citationInoue, N., & Russell, D. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7024-7031.1998 · Cited by 112
Ruffing, M., Zentgraf, H., & Kleinschmidt, J. A. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.6922-6930.1992 · Cited by 109 · cited 2×
“…or immunologic studies, virus-like particles, that is, shells without any viral nucleic acids, have been successfully synthesized in the baculovirus expression system, including AAV (Ruffing et al ., 1992), parvovirus B19 (Kajigaya et al ., 1991), and human papillomavirus (Kirnbauer et al ., 1993).”
Recent advances in recombinant adeno-associated virus vector production
Clark, K. R. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.0610s1009.x · Cited by 55
Bergoin, M., & Tijssen, P. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5341-0_6 · Cited by 48
Advances in vector-mediated gene transfer
Baum, B. J., Goldsmith, C. M., Kok, M. R., Lodde, B. M., van Mello, N. M., Voutetakis, A., Wang, J., Yamano, S., & Zheng, C. (2003) · Immunology Letters · doi:10.1016/j.imlet.2003.08.006 · Cited by 36
Utilizing endocrine secretory pathways in salivary glands for systemic gene therapeutics
Voutetakis, A., Wang, J., & Baum, B. J. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10429 · Cited by 16
Cited by
Baculovirus as versatile vectors for protein expression in insect and mammalian cells
Kost, T. A., Condreay, J. P., & Jarvis, D. L. (2005) · Nature Biotechnology · doi:10.1038/nbt1095 · Cited by 1,014
Adeno-associated Virus Serotypes: Vector Toolkit for Human Gene Therapy
Wu, Z., Asokan, A., & Samulski, R. J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.009 · Cited by 922
Adeno-associated virus as a delivery vector for gene therapy of human diseases
Wang, J.-H., Gessler, D. J., Zhan, W., Gallagher, T. L., & Gao, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01780-w · Cited by 904
Harper, S. Q., Staber, P. D., He, X., Eliason, S. L., Martins, I. H., Mao, Q., Yang, L., Kotin, R. M., Paulson, H. L., & Davidson, B. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501507102 · Cited by 682
Self-citationRNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia
Xia, H., Mao, Q., Eliason, S. L., Harper, S. Q., Martins, I. H., Orr, H. T., Paulson, H. L., Yang, L., Kotin, R. M., & Davidson, B. L. (2004) · Nature Medicine · doi:10.1038/nm1076 · Cited by 652
Self-citation
Metadata
- Authors
- Urabe, M., Ding, C., & Kotin, R. M.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2002-11
- Volume
- 13
- Issue
- 16
- Pages
- 1935-1943
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2174590326
- Cited by
- 457
- References
- 28
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.